Pharmacologic management of pain in patients with Chikungunya: a guideline

Detalhes bibliográficos
Autor(a) principal: Brito,Carlos Alexandre Antunes de
Data de Publicação: 2016
Outros Autores: Sohsten,Ana Karla Arraes von, Leitão,Clezio Cordeiro de Sá, Brito,Rita de Cássia Coelho Moraes de, Valadares,Lilian David De Azevedo, Fonte,Caroline Araújo Magnata da, Mesquita,Zelina Barbosa de, Cunha,Rivaldo Venâncio, Luz,Kleber, Leão,Helena Maria Carneiro, Brito,Cecília Moraes de, Frutuoso,Lívia Carla Vinhal
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Sociedade Brasileira de Medicina Tropical
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668
Resumo: Abstract From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is characterized by swelling and intense pain that is poorly responsive to analgesics, both in the acute and chronic phase of the disease. This significantly compromises quality of life and may have immeasurable psychosocial and economic repercussions, constituting therefore, a serious public health problem requiring a targeted approach. Physicians are often not familiar with how to approach the management of pain, frequently prescribing limited analgesics, such as dipyrone, in sub-therapeutic doses. In addition, there are few published studies or guidelines on the approach to the treatment of pain in patients with Chikungunya. Some groups of specialists from different fields have thus developed a protocol for the pharmacologic treatment of Chikungunya-associated acute and chronic joint pain; this will be presented in this review.
id SBMT-1_48021fc027081cdf592e7db4da985d51
oai_identifier_str oai:scielo:S0037-86822016000600668
network_acronym_str SBMT-1
network_name_str Revista da Sociedade Brasileira de Medicina Tropical
repository_id_str
spelling Pharmacologic management of pain in patients with Chikungunya: a guidelineChikungunyaPainArthralgiaArbovirusTreatmentAbstract From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is characterized by swelling and intense pain that is poorly responsive to analgesics, both in the acute and chronic phase of the disease. This significantly compromises quality of life and may have immeasurable psychosocial and economic repercussions, constituting therefore, a serious public health problem requiring a targeted approach. Physicians are often not familiar with how to approach the management of pain, frequently prescribing limited analgesics, such as dipyrone, in sub-therapeutic doses. In addition, there are few published studies or guidelines on the approach to the treatment of pain in patients with Chikungunya. Some groups of specialists from different fields have thus developed a protocol for the pharmacologic treatment of Chikungunya-associated acute and chronic joint pain; this will be presented in this review.Sociedade Brasileira de Medicina Tropical - SBMT2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668Revista da Sociedade Brasileira de Medicina Tropical v.49 n.6 2016reponame:Revista da Sociedade Brasileira de Medicina Tropicalinstname:Sociedade Brasileira de Medicina Tropical (SBMT)instacron:SBMT10.1590/0037-8682-0279-2016info:eu-repo/semantics/openAccessBrito,Carlos Alexandre Antunes deSohsten,Ana Karla Arraes vonLeitão,Clezio Cordeiro de SáBrito,Rita de Cássia Coelho Moraes deValadares,Lilian David De AzevedoFonte,Caroline Araújo Magnata daMesquita,Zelina Barbosa deCunha,Rivaldo VenâncioLuz,KleberLeão,Helena Maria CarneiroBrito,Cecília Moraes deFrutuoso,Lívia Carla Vinhaleng2017-01-31T00:00:00Zoai:scielo:S0037-86822016000600668Revistahttps://www.sbmt.org.br/portal/revista/ONGhttps://old.scielo.br/oai/scielo-oai.php||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br1678-98490037-8682opendoar:2017-01-31T00:00Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)false
dc.title.none.fl_str_mv Pharmacologic management of pain in patients with Chikungunya: a guideline
title Pharmacologic management of pain in patients with Chikungunya: a guideline
spellingShingle Pharmacologic management of pain in patients with Chikungunya: a guideline
Brito,Carlos Alexandre Antunes de
Chikungunya
Pain
Arthralgia
Arbovirus
Treatment
title_short Pharmacologic management of pain in patients with Chikungunya: a guideline
title_full Pharmacologic management of pain in patients with Chikungunya: a guideline
title_fullStr Pharmacologic management of pain in patients with Chikungunya: a guideline
title_full_unstemmed Pharmacologic management of pain in patients with Chikungunya: a guideline
title_sort Pharmacologic management of pain in patients with Chikungunya: a guideline
author Brito,Carlos Alexandre Antunes de
author_facet Brito,Carlos Alexandre Antunes de
Sohsten,Ana Karla Arraes von
Leitão,Clezio Cordeiro de Sá
Brito,Rita de Cássia Coelho Moraes de
Valadares,Lilian David De Azevedo
Fonte,Caroline Araújo Magnata da
Mesquita,Zelina Barbosa de
Cunha,Rivaldo Venâncio
Luz,Kleber
Leão,Helena Maria Carneiro
Brito,Cecília Moraes de
Frutuoso,Lívia Carla Vinhal
author_role author
author2 Sohsten,Ana Karla Arraes von
Leitão,Clezio Cordeiro de Sá
Brito,Rita de Cássia Coelho Moraes de
Valadares,Lilian David De Azevedo
Fonte,Caroline Araújo Magnata da
Mesquita,Zelina Barbosa de
Cunha,Rivaldo Venâncio
Luz,Kleber
Leão,Helena Maria Carneiro
Brito,Cecília Moraes de
Frutuoso,Lívia Carla Vinhal
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Brito,Carlos Alexandre Antunes de
Sohsten,Ana Karla Arraes von
Leitão,Clezio Cordeiro de Sá
Brito,Rita de Cássia Coelho Moraes de
Valadares,Lilian David De Azevedo
Fonte,Caroline Araújo Magnata da
Mesquita,Zelina Barbosa de
Cunha,Rivaldo Venâncio
Luz,Kleber
Leão,Helena Maria Carneiro
Brito,Cecília Moraes de
Frutuoso,Lívia Carla Vinhal
dc.subject.por.fl_str_mv Chikungunya
Pain
Arthralgia
Arbovirus
Treatment
topic Chikungunya
Pain
Arthralgia
Arbovirus
Treatment
description Abstract From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is characterized by swelling and intense pain that is poorly responsive to analgesics, both in the acute and chronic phase of the disease. This significantly compromises quality of life and may have immeasurable psychosocial and economic repercussions, constituting therefore, a serious public health problem requiring a targeted approach. Physicians are often not familiar with how to approach the management of pain, frequently prescribing limited analgesics, such as dipyrone, in sub-therapeutic doses. In addition, there are few published studies or guidelines on the approach to the treatment of pain in patients with Chikungunya. Some groups of specialists from different fields have thus developed a protocol for the pharmacologic treatment of Chikungunya-associated acute and chronic joint pain; this will be presented in this review.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0037-8682-0279-2016
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
dc.source.none.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical v.49 n.6 2016
reponame:Revista da Sociedade Brasileira de Medicina Tropical
instname:Sociedade Brasileira de Medicina Tropical (SBMT)
instacron:SBMT
instname_str Sociedade Brasileira de Medicina Tropical (SBMT)
instacron_str SBMT
institution SBMT
reponame_str Revista da Sociedade Brasileira de Medicina Tropical
collection Revista da Sociedade Brasileira de Medicina Tropical
repository.name.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)
repository.mail.fl_str_mv ||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br
_version_ 1752122160542908416